Cargando…
Evaluating the Diagnostic Accuracy of Xpert MTB/RIF Assay in Pulmonary Tuberculosis
Pulmonary tuberculosis still remains a major communicable disease worldwide. In 2013, 9 million people developed TB and 1.5 million people died from the disease. India constitutes 24% of the total TB burden. Early detection of TB cases is the key to successful treatment and reduction of disease tran...
Autores principales: | Sharma, Surendra K, Kohli, Mikashmi, Yadav, Raj Narayan, Chaubey, Jigyasa, Bhasin, Dinkar, Sreenivas, Vishnubhatla, Sharma, Rohini, Singh, Binit K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619889/ https://www.ncbi.nlm.nih.gov/pubmed/26496123 http://dx.doi.org/10.1371/journal.pone.0141011 |
Ejemplares similares
-
Comparative Performance of Line Probe Assay (Version 2) and Xpert MTB/RIF Assay for Early Diagnosis of Rifampicin-Resistant Pulmonary Tuberculosis
por: Yadav, Raj Narayan, et al.
Publicado: (2021) -
Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
por: Kumar, Suraj, et al.
Publicado: (2017) -
Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021) -
Diagnostic utility of a line probe assay for multidrug resistant-TB in smear-negative pulmonary tuberculosis
por: Singh, Binit Kumar, et al.
Publicado: (2017) -
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)